Prolium Bioscience
Pre-clinicalProlium Bioscience is a clinical-stage biotech company committed to delivering breakthrough therapies for autoimmune disease by combining scientific rigor and deep compassion – bringing hope and healing to patients who need it most.
Founded
2018
Focus
Small Molecules
About
Prolium Bioscience is a clinical-stage biotech company committed to delivering breakthrough therapies for autoimmune disease by combining scientific rigor and deep compassion – bringing hope and healing to patients who need it most.
Funding History
1Total raised: $4M
Seed$4MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile